Netherlands Wound Care Management Medical Equipment Industry Report

Netherlands Wound Care Management Medical Equipment Industry Report

Detailed Analysis of The Medical Equipment & Medical Devices Market Covering Advanced and Traditional Wound Management, Compression Therapy, Ostomy and Wound Closure Devices Medical Equipment and Supplies

This report is an essential source for in-depth information and data relating to Netherlands wound care management medical equipment market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the wound care management in Netherlands

Scope

• The report provides sector information broken down into detailed categories and segments in country.
• Total revenues, products sold, end users, and average pricing.
• Market shares of all the key competitors.
• Key pipeline products that are set to shape the market, broken down by sector.
• Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
• Key mergers and acquisitions, partnerships, private equity investments and IPOs.
• Customer, hospitals and physicians data.

Reasons to buy

• Gain a strong understanding of the industry at a global level, with break downs for the country
• Evaluate and compare the attractiveness of the market in the country.
• Identify growth segments and opportunities in each industry sector within the country.
• Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
• Analyze the competitiveness of the market in the country and identify hotspots.
• Develop strategies based on the latest product, brand, expansion and research and development news in the country.
• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
• Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Contents

• 1 Table Of Contents
  • 1.1 List of Tables
  • 1.2 List of Figures
• 2 Introduction
  • 2.1 What Is This Report About?
  • 2.2 Definitions
    • 2.2.1 Wound Care Management
• 3 Healthcare Sector Review
  • 3.1 Healthcare Expenditure
  • 3.2 Healthcare Infrastructure
  • 3.3 Healthcare Policy
    • 3.3.1 Health Insurance Act
    • 3.3.2 Healthcare Allowance Act
    • 3.3.3 The Exceptional Medical Expenses Act
• 4 Wound Care Management in Netherlands
  • 4.1 Wound Care Management Overall Revenues (2000-2012)
  • 4.2 Wound Care Management Overall Volume (2000-2012)
  • 4.3 Wound Care Management Overall Company Shares (2005-2006)
• 5 Wound Closure Devices in Netherlands
  • 5.1 Wound Closure Devices Overall Revenues (2000-2012)
    • 5.1.1 Skin Closure Devices Overall Revenues (2000-2012)
    • 5.1.2 Hemostats Overall Revenues (2000-2012)
    • 5.1.3 Tissue Sealants Overall Revenues (2000-2012)
  • 5.2 Wound Closure Devices Overall Volume (2000-2012)
    • 5.2.1 Skin Closure Devices Overall Volume (2000-2012)
    • 5.2.2 Tissue Sealants Overall Volume (2000-2012)
    • 5.2.3 Hemostats Overall Volume (2000-2012)
  • 5.3 Wound Closure Devices Average Price (2000-2012)
    • 5.3.1 Hemostats Average Price (2000-2012)
    • 5.3.2 Tissue Sealants Average Price (2000-2012)
    • 5.3.3 Skin Closure Devices Average Price (2000-2012)
  • 5.4 Wound Closure Devices Distribution Share (2000-2012)
  • 5.5 Wound Closure Devices Company Share (2000-2012)
• 6 Ostomy in Netherlands
  • 6.1 Ostomy Overall Revenue (2000-2012)
  • 6.2 Ostomy Overall Volume (2000-2012)
  • 6.3 Ostomy Average Price (2000-2012)
  • 6.4 Ostomy Distribution Share (2005-2006)
  • 6.5 Ostomy Company Share (2005-2006)
• 7 Advanced Wound Management in Netherlands
  • 7.1 Advanced Wound Management Overall Revenue (2000-2012)
  • 7.2 Advanced Wound Management Overall Volume (2000-2012)
  • 7.3 Advanced Wound Management Average Price (2000-2012)
  • 7.4 Advanced Wound Management Distribution Share (2005-2006)
  • 7.5 Advanced Wound Management Company Share (2005-2006)
• 8 Traditional Wound Management in Netherlands
  • 8.1 Traditional Wound Management Overall Revenue (2000-2012)
  • 8.2 Traditional Wound Management Overall Volume (2000-2012)
  • 8.3 Traditional Wound Management Average Price (2000-2012)
  • 8.4 Traditional Wound Management Distribution Share (2000-2012)
  • 8.5 Traditional Wound Management Company Share (2000-2012)
• 9 Compression Therapy in Netherlands
  • 9.1 Compression Therapy Overall Revenue (2000-2012)
  • 9.2 Compression Therapy Category Volume (2000-2012)
  • 9.3 Compression Therapy Average Price (2000-2012)
  • 9.4 Compression Therapy Distribution Share (2000-2012)
  • 9.5 Compression Therapy Company Share (2000-2012)
• 10 Baxter International Company Profile
  • 10.1 Company Overview
  • 10.2 Business Overview
    • 10.2.1 BioScience
    • 10.2.2 Medication Delivery
    • 10.2.3 Renal
    • 10.2.4 Products
    • 10.2.5 History
  • 10.3 Value Chain Analysis
    • 10.3.1 Manufacturing
    • 10.3.2 Product Development
    • 10.3.3 Sales and Marketing
  • 10.4 SWOT Analysis
    • 10.4.1 Baxter International Inc. Strengths
    • 10.4.2 Baxter International Inc. Weaknesses
    • 10.4.3 Baxter International Inc. Opportunities
    • 10.4.4 Baxter International Inc. Threats
  • 10.5 Financial and Operational Review
  • 10.6 Locations And Subsidiaries
  • 10.7 Financial Deals Landscape
    • 10.7.1 Baiyunshan And Baxter Form A Joint Venture In China
    • 10.7.2 Baxter Signs Licensing Agreement With Intercytex And Spinal Restoration
    • 10.7.3 Baxter Sells Transfusion Therapies Business to Texas Pacific and Maverick Capital
    • 10.7.4 B. Braun Acquires Renal Therapy Business Of Baxter
    • 10.7.5 Innovata signs a license agreement with Baxter International
    • 10.7.6 Kuros Biosurgery Signs An Agreement With Baxter International
    • 10.7.7 Gambro Signs An Agreement With Baxter
    • 10.7.8 Baxter Healthcare And Gambro Enter Into An Agreement
    • 10.7.9 Baxter and Cerus Enter Into Agreement With BioOne for Commercialization Of INTERCEPT Blood System
    • 10.7.10 Baxter International And Kaketsuken Enter Into Agreement
    • 10.7.11 Baxter To Acquire 40% Stake In Shanghai Baxter From Worldbest Treeful
  • 10.8 Recent Developments
    • 10.8.1 Jan 24, 2008: Baxter Achieves Record Sales and Earnings for Full-Year 2007
    • 10.8.2 Dec 18, 2007: Baxter Elects CFO
    • 10.8.3 Nov 13, 2007: Baxter Declares Quarterly Dividend
    • 10.8.4 Aug 01, 2007: Baxter Elects New Board Director
    • 10.8.5 Jul 31, 2007: Baxter Announces Quarterly Dividend
    • 10.8.6 Mar 13, 2007: Baxter Declares Additional Share Repurchase Authorization
    • 10.8.7 Feb 13, 2007: Baxter Announces Quarterly Dividend
    • 10.8.8 Nov 28, 2006: Baxter Announces Annual Dividend
    • 10.8.9 Sep 14, 2006: Baxter Appoints President, Baxter Latin America
  • 10.9 Baxter International Inc. Pipeline Products
    • 10.9.1 Next-Generation Home Hemodialysis Machine
• 11 Smith & Nephew Plc Company Profile
  • 11.1 Company Overview
  • 11.2 Business Overview
    • 11.2.1 Advanced Wound Management
    • 11.2.2 Endoscopy
    • 11.2.3 Reconstruction
    • 11.2.4 Trauma and Clinical Therapies
    • 11.2.5 Products
    • 11.2.6 History
  • 11.3 Value Chain Analysis
    • 11.3.1 Manufacturing
    • 11.3.2 Product Development
    • 11.3.3 Sales and Marketing
  • 11.4 SWOT Analysis
    • 11.4.1 Smith & Nephew Plc Strengths
    • 11.4.2 Smith & Nephew Plc Weaknesses
    • 11.4.3 Smith & Nephew Plc Opportunities
    • 11.4.4 Smith & Nephew Plc Threats
  • 11.5 Financial and Operational Review
  • 11.6 Locations And Subsidiaries
  • 11.7 Financial Deals Landscape
    • 11.7.1 Smith & Nephew Endoscopy Sells Its Vascular Business To InaVein
    • 11.7.2 Smith & Nephew Signs An Agreement With Universal Hospital Services
    • 11.7.3 Smith & Nephew Acquires Plus Orthopedics Holding
    • 11.7.4 Smith & Nephew And Teknimed Enter Into Distribution Agreement
    • 11.7.5 Smith & Nephew Acquires BlueSky Medical Group
    • 11.7.6 Smith & Nephew Enters Into An Agreement With Covalon
    • 11.7.7 Smith & Nephew Signs An Agreement With UDL Laboratories
    • 11.7.8 Nexa Orthopedics Signs An Agreement With Smith & Nephew
    • 11.7.9 Smith & Nephew Acquires Osteobiologics
    • 11.7.10 Smith & Nephew And Q-MED Enter Into Licensing Agreement
    • 11.7.11 Smith & Nephew Completes Sale Of 50% Interest In BSN Medical To Montagu Private Equity
    • 11.7.12 ArthroCare Enters Into Licensing Agreement With Smith & Nephew
    • 11.7.13 Smith & Nephew Signs Licensing Agreement With Alexandria Research Technologies
    • 11.7.14 Smith & Nephew Signs An Agreement With ORTHOsoft
    • 11.7.15 Osteotech And Smith & Nephew Enter Into Processing And Distribution Agreement
    • 11.7.16 Smith & Nephew Acquires VERSAJET From HydroCision
    • 11.7.17 Smith & Nephew Terminates Acquisition Of Biomet
  • 11.8 Recent Developments
    • 11.8.1 Apr 02, 2008: Smith & Nephew Declares Second Interim Dividend
    • 11.8.2 Apr 02, 2008: Smith & Nephew Reports 2007 Results
    • 11.8.3 Mar 23, 2008: Smith & Nephew, Corin Battle To Win Over America's Hip Generation
    • 11.8.4 Feb 29, 2008: Smith & Nephew Appoints SVP, GM
    • 11.8.5 Feb 20, 2008: Smith & Nephew and Synthes Settle Patent Dispute For Trochanteric Fixation Nails
    • 11.8.6 Oct 22, 2007: Smith & Nephew Declares Interim Dividend
    • 11.8.7 May 03, 2007: Smith & Nephew Appoints New CEO
  • 11.9 Smith & Nephew Plc Pipeline Products
    • 11.9.1 R3 Modular resurfacing Acetabular system
    • 11.9.2 R3 Ceramic-on-ceramic Acetabular System
• 12 The HARTMANN GROUP Company Profile
  • 12.1 Company Overview
  • 12.2 Business Overview
    • 12.2.1 Incontinence Management
    • 12.2.2 Operating Theater Management
    • 12.2.3 Other GROUP Activities
    • 12.2.4 Wound Management
    • 12.2.5 Products
    • 12.2.6 History
  • 12.3 Value Chain Analysis
    • 12.3.1 Manufacturing
    • 12.3.2 Product Development
    • 12.3.3 Sales and Marketing
  • 12.4 SWOT Analysis
    • 12.4.1 HARTMANN GROUP Strengths
    • 12.4.2 HARTMANN GROUP Weaknesses
    • 12.4.3 HARTMANN GROUP Opportunities
    • 12.4.4 HARTMANN GROUP Threats
  • 12.5 Financial and Operational Review
  • 12.6 Locations And Subsidiaries
  • 12.7 Recent Developments
    • 12.7.1 Mar 17, 2008: Hartmann Declares 2007 Results
    • 12.7.2 Jan 29, 2008: HARTMANN Establishes New Subsidiary In Siberia
    • 12.7.3 Jan 11, 2008: HARTMANN Launches New Subsidiary In Ulm
    • 12.7.4 Aug 10, 2007: Hartmann Reports H1 2007 Results
• 13 Coloplast A/S Company Profile
  • 13.1 Company Overview
  • 13.2 Business Overview
    • 13.2.1 Medical Care
    • 13.2.2 Major Products and Services
    • 13.2.3 History
  • 13.3 Value Chain Analysis
    • 13.3.1 Manufacturing
    • 13.3.2 Product Development
    • 13.3.3 Sales and Marketing
  • 13.4 SWOT Analysis
    • 13.4.1 Coloplast A/S Strengths
    • 13.4.2 Coloplast A/S Weaknesses
    • 13.4.3 Coloplast A/S Opportunities
    • 13.4.4 Coloplast A/S Threats
  • 13.5 Financial and Operational Review
    • 13.5.1 Financial Statements
    • 13.5.2 Financial Ratios
    • 13.5.3 Share Holding Structure
  • 13.6 Locations And Subsidiaries
  • 13.7 Financial Deals Landscape
    • 13.7.1 Coloplast Sells Brachytherapy Business To Core Oncology
    • 13.7.2 Coloplast Signs Distribution Agreement With Carbon Medical Technologies
    • 13.7.3 Granville Baird Capital Partners Advisors Acquires Coloplast's Business Unit
    • 13.7.4 McKesson Corporation Acquires Sterling Medical Services
    • 13.7.5 Coloplast Acquires Surgical Urology And Clinical And Consumer Healthcare Business Segments Of Mentor
  • 13.8 Recent Developments
    • 13.8.1 Apr 07, 2008: Coloplast Plans To Invest EUR100 Million In Hungary
    • 13.8.2 Feb 19, 2008: Coloplast Declares Q1 Fiscal 2008 Results
    • 13.8.3 Nov 20, 2007: Coloplast Declares Fiscal 2007 Results
    • 13.8.4 Aug 16, 2007: Coloplast Declares Nine Months Ended 2007 Results
    • 13.8.5 May 15, 2007: Colplast Declares H1 2007 Results
    • 13.8.6 Feb 08, 2007: Coloplast Declares Q1 Fiscal 2007 Results
    • 13.8.7 Dec 13, 2006: Coloplast Appoints New Chairman
    • 13.8.8 Nov 15, 2006: Coloplast Declares Fiscal 2006 Results
• 14 ConvaTec Company Profile
  • 14.1 Company Overview
  • 14.2 Business Overview
    • 14.2.1 Major Products and Services
    • 14.2.2 History
  • 14.3 Locations And Subsidiaries
  • 14.4 Recent Developments
    • 14.4.1 Jan 22, 2008: Vivolution Acquires Patent From BMS
    • 14.4.2 Nov 12, 2007: Alltracel Signs Development Agreement With ConvaTec
• 15 Regulation System
  • 15.1 Medical Equipment Approval Process
    • 15.1.1 Classification of Medical Devices
    • 15.1.2 Conformity Assessment Process
  • 15.2 Post Market Surveillance (PMS)
• 16 Pricing and Reimbursement
  • 16.1 Pricing and Reimbursement in Netherlands
• 17 Distribution Structure
  • 17.1 Distribution Structure in Netherlands
• 18 APPENDIX
  • 18.1 Global Markets Direct Research Methodology
  • 18.2 Coverage
  • 18.3 Secondary Research
  • 18.4 Primary Research
  • 18.5 Models
  • 18.6 Forecasts
  • 18.7 Expert Panels
  • 18.8 Currency Conversion
  • 18.9 Contact Us
  • 18.10 Disclaimer
• List of Tables
  • Table 1: Doctors by Specialty in Netherlands, 2000-2006
  • Table 2: Hospital Wards by Type in Netherlands, 2000-2006
  • Table 3: Wound Care Management, Netherlands, Overall Revenues ($ mn), 2000-2012
  • Table 4: Wound Care Management, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
  • Table 5: Wound Care Management, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
  • Table 6: Wound Care Management, Netherlands, Category Revenues ($ mn), 2000-2012
  • Table 7: Wound Care Management, Netherlands, Category Revenues ($ mn), Historic, 2000-2007
  • Table 8: Wound Care Management, Netherlands, Category Revenues ($ mn), Forecast, 2007-2012
  • Table 9: Wound Care Management, Netherlands, Category Volume (Units), 2000-2012
  • Table 10: Wound Care Management, Netherlands, Category Volume (Units), Historic, 2000-2007
  • Table 11: Wound Care Management, Netherlands, Category Volume (Units), Forecast, 2007-2012
  • Table 12: Wound Care Management, Netherlands, Overall Company Share by Revenue ($ mn), 2005-2006
  • Table 13: Wound Closure Devices, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
  • Table 14: Wound Closure Devices, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
  • Table 15: Wound Closure Devices, Netherlands, Revenue by Segment ($ mn), Historic, 2000-2007
  • Table 16: Wound Closure Devices, Netherlands, Revenue by Segment ($ mn), Forecast, 2007-2012
  • Table 17: Skin Closure Devices, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
  • Table 18: Skin Closure Devices, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
  • Table 19: Hemostats, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
  • Table 20: Hemostats, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
  • Table 21: Tissue Sealants, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
  • Table 22: Tissue Sealants, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
  • Table 23: Wound Closure Devices, Netherlands, Overall Volume (Units), Historic, 2000-2007
  • Table 24: Wound Closure Devices, Netherlands, Overall Volume (Units), Forecast, 2007-2012
  • Table 25: Skin Closure Devices, Netherlands, Overall Volume (Units), Historic, 2000-2007
  • Table 26: Skin Closure Devices, Netherlands, Overall Volume (Units), Forecast, 2007-2012
  • Table 27: Tissue Sealants, Netherlands, Overall Volume (Units), Historic, 2000-2007
  • Table 28: Tissue Sealants, Netherlands, Overall Volume (Units), Forecast, 2007-2012
  • Table 29: Hemostats, Netherlands, Overall Volume (Units), Historic, 2000-2007
  • Table 30: Hemostats, Netherlands, Overall Volume (Units), Forecast, 2007-2012
  • Table 31: Hemostats, Netherlands, Average Price ($), Historic, 2000-2007
  • Table 32: Hemostats, Netherlands, Average Price ($), Forecast, 2007-2012
  • Table 33: Tissue Sealants, Netherlands, Average Price ($), Historic, 2000-2007
  • Table 34: Tissue Sealants, Netherlands, Average Price ($), Forecast, 2007-2012
  • Table 35: Skin Closure Devices, Netherlands, Average Price ($), Historic, 2000-2007
  • Table 36: Skin Closure Devices, Netherlands, Average Price ($), Forecast, 2007-2012
  • Table 37: Wound Closure Devices, Netherlands, Distribution Share by Revenue ($ mn), 2005-2006
  • Table 38: Wound Closure Devices, Netherlands, Company Share by Revenue ($ mn), 2005-2006
  • Table 39: Ostomy, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
  • Table 40: Ostomy, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
  • Table 41: Ostomy, Netherlands, Overall Volume (Units), Historic, 2000-2007
  • Table 42: Ostomy, Netherlands, Overall Volume (Units), Forecast, 2007-2012
  • Table 43: Ostomy, Netherlands, Average Price ($), Historic, 2000-2007
  • Table 44: Ostomy, Netherlands, Average Price ($), Forecast, 2007-2012
  • Table 45: Ostomy, Netherlands, Distribution Share by Revenue ($ mn), 2005-2006
  • Table 46: Ostomy, Netherlands, Company Share by Revenue ($ mn), 2005-2006
  • Table 47: Advanced Wound Management, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
  • Table 48: Advanced Wound Management, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
  • Table 49: Advanced Wound Management, Netherlands, Overall Volume (Units), Historic, 2000-2007
  • Table 50: Advanced Wound Management, Netherlands, Overall Volume (Units), Forecast, 2007-2012
  • Table 51: Advanced Wound Management, Netherlands, Average Price ($), Historic, 2000-2007
  • Table 52: Advanced Wound Management, Netherlands, Average Price ($), Forecast, 2007-2012
  • Table 53: Advanced Wound Management, Netherlands, Distribution Share by Revenue ($ mn), 2005-2006
  • Table 54: Advanced Wound Management, Netherlands, Company Share by Revenue ($ mn), 2005-2006
  • Table 55: Traditional Wound Management, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
  • Table 56: Traditional Wound Management, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
  • Table 57: Traditional Wound Management, Netherlands, Overall Volume (Units), Historic, 2000-2007
  • Table 58: Traditional Wound Management, Netherlands, Overall Volume (Units), Forecast, 2007-2012
  • Table 59: Traditional Wound Management, Netherlands, Average Price ($), Historic, 2000-2007
  • Table 60: Traditional Wound Management, Netherlands, Average Price ($), Forecast, 2007-2012
  • Table 61: Traditional Wound Management, Netherlands, Distribution Share by Revenue ($ mn), 2005-2006
  • Table 62: Traditional Wound Management, Netherlands, Company Share by Revenue ($ mn), 2005-2006
  • Table 63: Compression Therapy, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
  • Table 64: Compression Therapy, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
  • Table 65: Compression Therapy, Netherlands, Overall Volume (Units), Historic, 2000-2007
  • Table 66: Compression Therapy, Netherlands, Overall Volume (Units), Forecast, 2007-2012
  • Table 67: Compression Therapy, Netherlands, Average Price ($), Historic, 2000-2007
  • Table 68: Compression Therapy, Netherlands, Average Price ($), Forecast, 2007-2012
  • Table 69: Compression Therapy, Netherlands, Distribution Share by Revenue ($ mn), 2005-2006
  • Table 70: Compression Therapy, Netherlands, Company Share by Revenue ($ mn), 2005-2006
  • Table 71: Baxter International Inc., SWOT Analysis, 2006
  • Table 72: Baxter International Inc., Financial Statements, USD Million, 2002-2006
  • Table 73: Baxter International Inc., Financial Ratios, USD Million, 2002-2006
  • Table 74: Baxter International Inc., Other Locations
  • Table 75: Baxter International Inc., Subsidiaries
  • Table 76: Smith & Nephew Plc, SWOT Analysis, 2006
  • Table 77: Smith & Nephew Plc, Financial Statements, USD Million, 2002-2006
  • Table 78: Smith & Nephew Plc, Financial Ratios, USD Million, 2002-2006
  • Table 79: Smith & Nephew Plc, Other Locations
  • Table 80: HARTMANN GROUP, SWOT Analysis, 2006
  • Table 81: HARTMANN GROUP, Financial Statements, Euro Thousand, 2002-2006
  • Table 82: HARTMANN GROUP, Financial Ratios, Euro Thousand, 2002-2006
  • Table 83: HARTMANN GROUP, Subsidiaries
  • Table 84: Coloplast A/S, SWOT Analysis, 2007
  • Table 85: Coloplast A/S, Financial Statements, DKK Million, 2003-2007
  • Table 86: Coloplast A/S, Financial Ratios, DKK Million, 2003-2007
  • Table 87: Coloplast A/S, Share Holding Structure
  • Table 88: Coloplast A/S, Other Locations
  • Table 89: Coloplast A/S, Subsidiaries
  • Table 90: ConvaTec, Other Locations
  • Table 91: Currency Conversion from USD to Local Currency at 2007 Constant Rate
• List of Figures
  • Figure 1: Total Healthcare Expenditure in Netherlands, 2000 - 2006
  • Figure 2: Healthcare Financing Framework in Netherlands, 2005
  • Figure 3: Wound Care Management, Netherlands, Overall Revenues ($ mn), 2000-2012
  • Figure 4: Wound Care Management, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 5: Wound Care Management, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 6: Wound Care Management, Netherlands, Category Revenues ($ mn), 2000-2012
  • Figure 7: Wound Care Management, Netherlands, Category Revenues ($ mn), Historic, 2000-2007
  • Figure 8: Wound Care Management, Netherlands, Category Revenues ($ mn), Forecast, 2007-2012
  • Figure 9: Wound Care Management, Netherlands, Category Volume (Units), 2000-2012
  • Figure 10: Wound Care Management, Netherlands, Category Volume (Units), Historic, 2000-2007
  • Figure 11: Wound Care Management, Netherlands, Category Volume (Units), Forecast, 2007-2012
  • Figure 12: Wound Care Management, Netherlands, Overall Company Share (%), 2006
  • Figure 13: Wound Closure Devices, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 14: Wound Closure Devices, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 15: Wound Closure Devices, Netherlands, Revenue by Segment ($ mn), Historic, 2000-2007
  • Figure 16: Wound Closure Devices, Netherlands, Revenue by Segment ($ mn), Forecast, 2007-2012
  • Figure 17: Skin Closure Devices, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 18: Skin Closure Devices, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 19: Hemostats, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 20: Hemostats, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 21: Tissue Sealants, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 22: Tissue Sealants, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 23: Wound Closure Devices, Netherlands, Overall Volume (Units), Historic, 2000-2007
  • Figure 24: Wound Closure Devices, Netherlands, Overall Volume (Units), Forecast, 2007-2012
  • Figure 25: Skin Closure Devices, Netherlands, Overall Volume (Units), Historic, 2000-2007
  • Figure 26: Skin Closure Devices, Netherlands, Overall Volume (Units), Forecast, 2007-2012
  • Figure 27: Tissue Sealants, Netherlands, Overall Volume (Units), Historic, 2000-2007
  • Figure 28: Tissue Sealants, Netherlands, Overall Volume (Units), Forecast, 2007-2012
  • Figure 29: Hemostats, Netherlands, Overall Volume (Units), Historic, 2000-2007
  • Figure 30: Hemostats, Netherlands, Overall Volume (Units), Forecast, 2007-2012
  • Figure 31: Hemostats, Netherlands, Average Price ($), Historic, 2000-2007
  • Figure 32: Hemostats, Netherlands, Average Price ($), Forecast, 2007-2012
  • Figure 33: Tissue Sealants, Netherlands, Average Price ($), Historic, 2000-2007
  • Figure 34: Tissue Sealants, Netherlands, Average Price ($), Forecast, 2007-2012
  • Figure 35: Skin Closure Devices, Netherlands, Average Price ($), Historic, 2000-2007
  • Figure 36: Skin Closure Devices, Netherlands, Average Price ($), Forecast, 2007-2012
  • Figure 37: Wound Closure Devices, Netherlands, Distribution Share (%), 2006
  • Figure 38: Wound Closure Devices, Netherlands, Company Share (%), 2006
  • Figure 39: Ostomy, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 40: Ostomy, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 41: Ostomy, Netherlands, Overall Volume (Units), Historic, 2000-2007
  • Figure 42: Ostomy, Netherlands, Overall Volume (Units), Forecast, 2007-2012
  • Figure 43: Ostomy, Netherlands, Average Price ($), Historic, 2000-2007
  • Figure 44: Ostomy, Netherlands, Average Price ($), Forecast, 2007-2012
  • Figure 45: Ostomy, Netherlands, Company Share (%), 2006
  • Figure 46: Advanced Wound Management, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 47: Advanced Wound Management, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 48: Advanced Wound Management, Netherlands, Overall Volume (Units), Historic, 2000-2007
  • Figure 49: Advanced Wound Management, Netherlands, Overall Volume (Units), Forecast, 2007-2012
  • Figure 50: Advanced Wound Management, Netherlands, Average Price ($), Historic, 2000-2007
  • Figure 51: Advanced Wound Management, Netherlands, Average Price ($), Forecast, 2007-2012
  • Figure 52: Advanced Wound Management, Netherlands, Distribution Share (%), 2006
  • Figure 53: Advanced Wound Management, Netherlands, Company Share (%), 2006
  • Figure 54: Traditional Wound Management, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 55: Traditional Wound Management, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 56: Traditional Wound Management, Netherlands, Overall Volume (Units), Historic, 2000-2007
  • Figure 57: Traditional Wound Management, Netherlands, Overall Volume (Units), Forecast, 2007-2012
  • Figure 58: Traditional Wound Management, Netherlands, Average Price ($), Historic, 2000-2007
  • Figure 59: Traditional Wound Management, Netherlands, Average Price ($), Forecast, 2007-2012
  • Figure 60: Traditional Wound Management, Netherlands, Distribution Share (%), 2006
  • Figure 61: Traditional Wound Management, Netherlands, Company Share (%), 2006
  • Figure 62: Compression Therapy, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 63: Compression Therapy, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 64: Compression Therapy, Netherlands, Overall Volume (Units), Historic, 2000-2007
  • Figure 65: Compression Therapy, Netherlands, Overall Volume (Units), Forecast, 2007-2012
  • Figure 66: Compression Therapy, Netherlands, Average Price ($), Historic, 2000-2007
  • Figure 67: Compression Therapy, Netherlands, Average Price ($), Forecast, 2007-2012
  • Figure 68: Compression Therapy, Netherlands, Distribution Share (%), 2006
  • Figure 69: Compression Therapy, Netherlands, Company Share (%), 2006
  • Figure 70: Baxter International Inc., Value Chain Analysis
  • Figure 71: Smith & Nephew Plc, Value Chain Analysis
  • Figure 72: HARTMANN GROUP, Value Chain Analysis
  • Figure 73: Coloplast A/S, Value Chain Analysis
  • Figure 74: Flowchart for Classification of Non-invasive Devices in Netherlands, 2007
  • Figure 75: Flowchart for Classification of Invasive Devices in Netherlands, 2007
  • Figure 76: Flowchart for Classification of Invasive Devices in Netherlands, 2007
  • Figure 77: Flowchart for Classification of Invasive Devices in Netherlands, 2007
  • Figure 78: Flowchart for Classification of Invasive Devices in Netherlands, 2007
  • Figure 79: Flowchart for Classification of Active Devices in Netherlands, 2007
  • Figure 80: Flowchart for Classification of Active Devices in Netherlands, 2007
  • Figure 81: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in Netherlands, 2007
  • Figure 82: Conformity Assessment of Class-I Medical Devices in Netherlands, 2007
  • Figure 83: Conformity Assessment of Class-IIa Medical Devices in Netherlands, 2007
  • Figure 84: Conformity Assessment of Class-IIb Medical Devices in Netherlands, 2007
  • Figure 85: Conformity Assessment of Class-III Medical Devices in Netherlands, 2007
  • Figure 86: Global Markets Direct Methodology

Related products